Journal Science Initiation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Journal Science Initiation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Journal Science Initiation Today - Breaking & Trending Today

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q4 2022 Earnings Call Transcript

Published: April 8, 2023

Operator: Good morning and welcome to the Inhibikase Fourth Quarter and Full Year 2022 Earnings Conference Call. Please note, today's event is being recorded.

Source: insidermonkey.com

Related Topics:

Joe FrattaroliJoseph FrattaroliMilton WernerAlex LoboNational Cancer Institute On UnsplashHealth PhotoInhibikase Therapeutics IncInhibikase TherapeuticsCall Transcript AprilInhibikase Fourth QuarterFull YearChief Executive OfficerChief FinancialInvestor RelationsPrivate Securities Litigation Reform ActMultiple System AtrophyStable Phase Chronic Myologic LeukemiaAbelson Tyrosine KinasesNational Cancer InstituteJournal Science InitiationChronic Myelogenous LeukemiaChief Financial OfficerWallstreetbets Stocks To Buy